ENTRY       D04340            Mixture   Drug
NAME        Dextromethorphan hydrobromide and potassium cresolsulfonate;
            Medicon (TN)
COMPONENT   Dextromethorphan hydrobromide [DR:D00848], Potassium cresolsulfonate [DR:D04339]
CLASS       Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 2249
            ATC code: R05FA02
            Product: D04340<JP>
EFFICACY    Antitussive, Expectorant
METABOLISM  Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R05 COUGH AND COLD PREPARATIONS
               R05F COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS
                R05FA Opium derivatives and expectorants
                 R05FA02 Opium derivatives and expectorants
                  D04340  Dextromethorphan hydrobromide and potassium cresolsulfonate &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              22  Respiratory organ agents
               224  Antitussives and expectorants
                2249  Others
                 D04340  Dextromethorphan hydrobromide and potassium cresolsulfonate
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               D04340  Dextromethorphan hydrobromide and potassium cresolsulfonate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D04340  Dextromethorphan hydrobromide and potassium cresolsulfonate
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D04340
DBLINKS     PubChem: 17398062
///
